GRTSQ — Gritstone bio Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$15.21m
- $16.34m
Annual income statement for Gritstone bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.37 | 4.04 | 48.2 | 19.9 | 16.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 102 | 110 | 123 | 140 | 156 |
| Operating Profit | -97.9 | -106 | -75.2 | -120 | -140 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -94.4 | -105 | -75.1 | -120 | -138 |
| Net Income After Taxes | -94.4 | -105 | -75.1 | -120 | -138 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -94.4 | -105 | -75.1 | -120 | -138 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -94.4 | -105 | -75.1 | -120 | -138 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.81 | -2.79 | -0.952 | -1.32 | -1.5 |